Focal Laser Treatment for Macular Edema
Understanding Focal Laser Treatment
Focal laser treatment uses a carefully controlled beam of light to seal tiny, leaking blood vessels in the retina. These leaking vessels, often called microaneurysms, allow fluid and blood components to seep into surrounding retinal tissue. When this fluid collects in the macula (the central area of the retina that provides detailed, color vision), it causes swelling known as macular edema.
By creating microscopic scars at the site of each leaking vessel, the laser stops or reduces the leakage. Once the source of fluid is sealed, the eye gradually reabsorbs the remaining fluid over weeks to months. This process can stabilize vision and, in some cases, lead to modest improvement.
The term 'focal laser' refers specifically to targeting individual leaking microaneurysms. A related technique called 'grid laser' applies a pattern of small laser spots across a broader area of swelling. This is used when there is no single identifiable source of leakage. Retina specialists often combine both techniques in a single session, which is why you may hear the procedure called 'focal/grid laser.'
This is different from panretinal photocoagulation (PRP), which treats the peripheral retina to manage severe proliferative diabetic retinopathy. Focal laser is a more targeted, limited treatment focused on the central retina.
The exact mechanism is not fully understood, but researchers have proposed several explanations. One theory is that the laser directly seals leaking microaneurysms. This allows the retinal pigment epithelium (RPE), a layer of cells beneath the retina, to recover and pump fluid away more effectively. Another theory suggests that reducing metabolically active retinal tissue improves oxygen delivery to the macula. This in turn decreases the drive for fluid leakage. Studies have shown that grid laser alone can also reduce macular edema, suggesting the laser has beneficial indirect effects beyond simply plugging leaks.
Who May Benefit and Risk Factors
Focal laser treatment is most commonly used for two conditions:
- Diabetic macular edema (DME): fluid buildup in the macula caused by damaged blood vessels from diabetes
- Branch retinal vein occlusion (BRVO): a blockage in one of the small veins draining the retina, which causes leakage and swelling
Diabetic macular edema affects approximately 3.8% of people aged 40 and older who have diabetes in the United States. This translates to roughly 746,000 individuals (Varma et al., 2014, NIH/PMC). The prevalence of DME among commercially insured adults has been rising, increasing from 0.7% to 2.6% between 2009 and 2018 (CDC, 2023).
Several factors increase the likelihood of developing DME. Having diabetes for 10 years or longer raises the odds significantly, with an odds ratio of 8.51 (Varma et al., 2014, NIH/PMC). Higher levels of hemoglobin A1c, a measure of long-term blood sugar control, are also strongly linked to DME risk. Each a small percentage increase in A1c raises the odds by a substantial proportion (Varma et al., 2014, NIH/PMC). Non-Hispanic Black individuals face a higher burden of DME compared to non-Hispanic white individuals, with an odds ratio of 2.64 (Varma et al., 2014, NIH/PMC).
Before anti-VEGF medications were approved for eye use, focal and grid laser photocoagulation was the standard treatment for clinically significant macular edema (CSME). Today, anti-VEGF injections such as Eylea (aflibercept), Lucentis (ranibizumab), Avastin (bevacizumab, used off-label for eye conditions), and Vabysmo (faricimab) are typically the first-line treatment for DME involving the center of the macula.
Focal laser is now primarily indicated for patients with non-center-involving DME. This means the swelling has not yet reached the very center of the macula. It may also be recommended as an add-on to anti-VEGF therapy to reduce the total number of injections needed over time. In parts of the world where access to anti-VEGF agents is limited, focal laser remains a primary treatment option.
Signs and Symptoms of Macular Edema
Macular edema can develop gradually, and early stages may not cause obvious symptoms. As fluid accumulates and the macula swells, you may begin to notice changes in your central vision. Common symptoms include:
- Blurry or hazy central vision
- Straight lines appearing wavy or distorted
- Colors appearing washed out or faded
- Difficulty reading or recognizing faces
- A dark or blank spot near the center of your visual field
The photoreceptor cells in the macula are responsible for the sharp, detailed vision you use for reading, driving, and recognizing faces. When fluid buildup persists, it can cause lasting damage to these cells. If left untreated, macular edema can lead to progressive and significant vision loss. This is why regular dilated eye exams are critical for anyone with diabetes or a history of retinal vein occlusion.
If you notice a sudden increase in blurriness, new distortion in your central vision, or a dark shadow across your visual field, see a retina specialist or go to the emergency room immediately. Sudden changes can indicate worsening edema or other serious retinal problems that require prompt evaluation.
Diagnosis and Testing
A retina specialist diagnoses macular edema during a comprehensive dilated eye exam. Using a slit lamp (a specialized microscope) and magnifying lenses, the specialist can directly view the retina. Signs include swelling, leaking blood vessels, and hard exudates (yellowish deposits left behind by leaking fluid).
The Early Treatment Diabetic Retinopathy Study (ETDRS) established a clinical definition of clinically significant macular edema. The criteria include retinal thickening within 500 micrometers of the center of the macula, hard exudates within 500 micrometers of the center with associated thickening, or a zone of thickening larger than one disc area with any part within one disc diameter of the center.
Optical coherence tomography (OCT) is a noninvasive scan that creates detailed cross-sectional images of the retina. It measures the exact thickness of the macula and reveals where fluid has collected. OCT is the primary tool retina specialists use to monitor macular edema and assess treatment response.
Fluorescein angiography (FA) involves injecting a yellow dye into a vein in the arm and photographing it as it flows through the retinal blood vessels. This test highlights specific microaneurysms and areas of leakage that may be targeted during focal laser treatment. FA is particularly helpful for planning laser sessions because it maps the exact locations of leaking vessels.
Modern laser systems can use digital images from angiography to plan treatment with high precision. One study using the Navilas navigated laser system showed that 96% of laser spots landed within 100 micrometers of the intended target (Navilas study, Ophthalmology research). This kind of precision helps retina specialists treat leaking vessels accurately while minimizing exposure to surrounding healthy tissue.
The Focal Laser Procedure
Focal laser treatment is performed as an outpatient procedure in a retina specialist's office. It typically takes 15 to 30 minutes. Before the procedure, the specialist will dilate your pupils using eye drops. You will also receive numbing drops or a small injection of local anesthetic near the eye to minimize discomfort. There is no need for general anesthesia, and you will be awake throughout.
You should arrange for someone to drive you home after the appointment. Your pupils will remain dilated and your vision may be blurry for several hours.
You will sit at a slit lamp, the same type of instrument used during a routine eye exam. A special contact lens is placed on the surface of the eye to focus the laser beam and hold the eye steady. The retina specialist then delivers a series of brief, controlled laser pulses to the targeted areas of the retina.
Each laser pulse lasts a fraction of a second and creates a tiny spot of controlled thermal energy on the retina. You may see flashes of light and feel a mild sensation with each pulse. Most patients describe the procedure as tolerable with minimal discomfort. A typical session involves roughly 100 laser spots, though this varies depending on the extent of leakage.
After the procedure, your vision may be slightly blurry and you may notice some mild aching or sensitivity to light. These effects usually resolve within a day or two. The retina specialist may recommend over-the-counter pain medication if needed. Strenuous activity should be avoided for a short period as directed by your specialist.
Treatment Outcomes and What to Expect
The landmark ETDRS trial demonstrated that focal and grid laser photocoagulation reduced the risk of moderate visual loss. Moderate visual loss was defined as a loss of 15 or more letters on a vision chart. The risk dropped from a substantial proportion to a notable percentage over three years in patients with clinically significant macular edema (AAO EyeWiki, ETDRS). This means the treatment cut the risk of significant vision loss in half.
Focal laser is primarily a stabilizing treatment. The main goal is to prevent further vision loss rather than to restore vision that has been lost. Some patients do experience modest improvement, but outcomes vary depending on the severity and duration of edema before treatment.
The effects of focal laser treatment are not immediate. It typically takes several weeks to a few months for the sealed vessels to stop leaking completely. The eye then gradually reabsorbs the remaining fluid. Your retina specialist will schedule follow-up visits to monitor your progress using OCT scans. Additional laser sessions may be needed if leakage persists or new leaking vessels develop.
In current practice, many retina specialists use focal laser as an adjunct to anti-VEGF therapy. A study examining adjunct nondamaging focal laser therapy found a significant reduction in injection frequency (DME adjunct laser study). The mean number of intravitreal injections decreased from 3.39 in the six months before laser to 2.33 in the six months after. This reduction occurred without compromising visual acuity or macular thickness.
Focal laser is considered a safe procedure when performed by an experienced retina specialist, but no medical procedure is without risk. Potential complications include:
- Small blind spots (scotomas) in the treated areas, which are usually not noticeable but can sometimes be perceived
- Inadvertent damage to the fovea (the very center of the macula) if laser is applied too close, which can cause severe central vision loss
- Formation of subretinal fibrosis (scar tissue beneath the retina), which can extend up to 900 micrometers from laser burn centers (focal argon laser study)
- Temporary increase in macular swelling shortly after treatment
- Changes in color perception in rare cases
Living with Macular Edema After Treatment
Focal laser treatment addresses existing leakage, but it does not eliminate the underlying disease that caused the leaking vessels. If you have diabetes, managing your blood sugar, blood pressure, and cholesterol remains critical for protecting your vision long-term. Regular follow-up visits with your retina specialist, typically every few months, allow for early detection of recurrent edema or new areas of leakage.
Hemoglobin A1c levels and diabetes duration are among the strongest risk factors for developing and worsening macular edema. Working closely with your primary care doctor or endocrinologist to optimize blood sugar control is one of the most important steps you can take. Even small improvements in A1c can meaningfully reduce the progression of diabetic eye disease.
A healthy diet, regular physical activity, and taking prescribed medications consistently all contribute to better metabolic control and better retinal health.
If macular edema has caused some degree of lasting vision change, low-vision aids and rehabilitation services can help you make the most of your remaining vision. Tools such as magnifying devices, large-print materials, and specialized lighting can make daily tasks easier. Your retina specialist can provide a referral to a low-vision rehabilitation specialist if appropriate.
When to See a Retina Specialist
All people with diabetes should have a comprehensive dilated eye exam at least once a year. More frequent exams may be needed based on individual risk. Early detection of macular edema, before symptoms develop, offers the best chance of preserving vision through timely treatment.
Contact a retina specialist promptly if you notice any new or worsening changes in your central vision. This includes increased blurriness, new distortion of straight lines, or difficulty with tasks you could previously do without trouble. If you experience a sudden loss of vision, a sudden increase in floaters, or flashes of light, seek immediate care from a retina specialist or emergency room. These symptoms could indicate a serious retinal problem that needs urgent attention.
Questions and Answers
Most patients experience mild discomfort rather than significant pain during the procedure. Numbing drops or a local anesthetic injection are given before treatment to reduce sensation. You may feel a slight stinging or see bright flashes during the laser pulses. Some patients describe a dull ache during or after the session, which typically resolves within a day.
The number of sessions depends on the severity and extent of your macular edema. Some patients respond well after a single treatment, while others may need two or more sessions spaced several months apart. Your retina specialist will evaluate your response using OCT imaging at follow-up visits. Additional treatment will be recommended if leakage persists or recurs.
The primary goal of focal laser treatment is to stabilize your current level of vision by stopping or reducing fluid leakage. The ETDRS showed the treatment reduced the risk of moderate vision loss by half over three years (AAO EyeWiki, ETDRS). Some patients do experience modest improvement in visual acuity as the macula dries and swelling decreases, but results vary. It is more accurate to think of focal laser as a protective measure rather than a vision-restoring procedure.
If you are currently receiving anti-VEGF injections for macular edema, adding focal laser may help reduce the number of injections you need. Research has shown a significant decrease in injection frequency in the months following adjunct focal laser therapy (DME adjunct laser study). However, your retina specialist will determine the best treatment plan based on your specific condition. Focal laser does not replace anti-VEGF therapy in all cases, especially when edema involves the center of the macula.
Focal laser is generally well tolerated, but the laser spots do create lasting microscopic scars on the retina. These scars can sometimes cause small blind spots, though they are typically too small to affect daily vision. Studies have shown that scar tissue from laser burns can extend beyond the original treatment area over time (focal argon laser study). This is why retina specialists exercise particular caution when treating near the center of the macula. Serious long-term complications are uncommon when the procedure is performed by an experienced specialist.